05:59:58 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-09-10 Årsstämma 2025
2024-06-05 Bokslutskommuniké 2024
2024-03-08 Kvartalsrapport 2024-Q3
2023-12-15 Kvartalsrapport 2024-Q2
2023-10-09 Inlösen SECT B 1.1
2023-09-08 Ordinarie utdelning SECT B 0.00 SEK
2023-09-07 Årsstämma 2024
2023-09-05 Kvartalsrapport 2024-Q1
2023-06-02 Bokslutskommuniké 2023
2023-03-10 Kvartalsrapport 2023-Q3
2022-12-16 Kvartalsrapport 2023-Q2
2022-10-10 Inlösen SECT B 1
2022-09-09 Ordinarie utdelning SECT B 0.00 SEK
2022-09-08 Årsstämma 2023
2022-09-02 Kvartalsrapport 2023-Q1
2022-06-03 Bokslutskommuniké 2022
2022-03-09 Kvartalsrapport 2022-Q3
2021-12-10 Kvartalsrapport 2022-Q2
2021-10-18 Inlösen SECT B 0.9
2021-09-24 Split SECT B 1:5
2021-09-15 Ordinarie utdelning SECT B 0.00 SEK
2021-09-14 Årsstämma 2022
2021-09-03 Kvartalsrapport 2022-Q1
2021-06-02 Bokslutskommuniké 2021
2021-03-12 Kvartalsrapport 2021-Q3
2020-11-27 Kvartalsrapport 2021-Q2
2020-10-05 Inlösen SECT B 4.5
2020-09-09 Ordinarie utdelning SECT B 0.00 SEK
2020-09-08 Årsstämma 2021
2020-09-04 Kvartalsrapport 2021-Q1
2020-06-03 Bokslutskommuniké 2020
2020-03-04 Kvartalsrapport 2020-Q3
2019-11-28 Kvartalsrapport 2020-Q2
2019-10-02 Inlösen SECT B 4.5
2019-09-06 Ordinarie utdelning SECT B 0.00 SEK
2019-09-05 Årsstämma 2020
2019-09-03 Kvartalsrapport 2020-Q1
2019-05-28 Bokslutskommuniké 2019
2019-03-06 Kvartalsrapport 2019-Q3
2018-12-07 Kvartalsrapport 2019-Q2
2018-10-03 Inlösen SECT B 4.5
2018-09-07 Ordinarie utdelning SECT B 0.00 SEK
2018-09-06 Årsstämma 2019
2018-09-04 Kvartalsrapport 2019-Q1
2018-05-29 Bokslutskommuniké 2018
2018-03-12 Kvartalsrapport 2018-Q3
2017-12-08 Kvartalsrapport 2018-Q2
2017-10-02 Inlösen SECT B 4.5
2017-09-14 Ordinarie utdelning SECT B 0.00 SEK
2017-09-13 Årsstämma 2018
2017-09-12 Kvartalsrapport 2018-Q1
2017-05-30 Bokslutskommuniké 2017
2017-03-07 Kvartalsrapport 2017-Q3
2016-12-07 Kvartalsrapport 2017-Q2
2016-10-04 Inlösen SECT B 4.5
2016-09-07 Ordinarie utdelning SECT B 0.00 SEK
2016-09-06 Årsstämma 2017
2016-09-05 Kvartalsrapport 2017-Q1
2016-05-31 Bokslutskommuniké 2016
2016-03-08 Kvartalsrapport 2016-Q3
2015-12-08 Kvartalsrapport 2016-Q2
2015-09-28 Inlösen SECT B 4.5
2015-09-15 Kapitalmarknadsdag 2015
2015-09-08 Ordinarie utdelning SECT B 0.00 SEK
2015-09-07 Årsstämma 2016
2015-09-07 Kvartalsrapport 2016-Q1
2015-06-03 Bokslutskommuniké 2015
2015-03-10 Kvartalsrapport 2015-Q3
2014-12-09 Kvartalsrapport 2015-Q2
2014-09-25 Inlösen SECT B 4.5
2014-09-09 Ordinarie utdelning SECT B 0.00 SEK
2014-09-08 Årsstämma 2015
2014-09-08 Kvartalsrapport 2015-Q1
2014-05-27 Bokslutskommuniké 2014
2014-03-04 Kvartalsrapport 2014-Q3
2013-12-10 Kvartalsrapport 2014-Q2
2013-09-10 Kvartalsrapport 2014-Q1
2013-07-11 Inlösen SECT B 4.5
2013-06-28 Ordinarie utdelning SECT B 0.00 SEK
2013-06-27 Årsstämma 2013
2013-05-29 Bokslutskommuniké 2013
2013-05-28 Bokslutskommuniké 2012
2013-05-28 Analytiker möte 2013
2013-03-06 Kapitalmarknadsdag 2013
2013-03-05 Kvartalsrapport 2012-Q3
2012-12-04 Kvartalsrapport 2012-Q2
2012-09-04 Kvartalsrapport 2012-Q1
2012-07-12 Inlösen SECT B 5
2012-06-29 Ordinarie utdelning SECT B 0.00 SEK
2012-06-28 Årsstämma 2011
2012-05-22 Analytiker möte 2011
2012-05-21 Bokslutskommuniké 2011
2012-03-05 Kvartalsrapport 2011-Q3
2011-12-06 15-7 2011
2011-12-05 Inlösen SECT B 5
2011-12-04 Kvartalsrapport 2011-Q2
2011-11-23 Ordinarie utdelning SECT B 0.00 SEK
2011-11-22 Extra Bolagsstämma 2011
2011-09-04 Kvartalsrapport 2011-Q1
2011-05-24 Bokslutskommuniké 2010
2011-03-08 Kvartalsrapport 2010-Q3
2010-07-01 Ordinarie utdelning SECT B 0.00 SEK
2010-06-30 Årsstämma 2010
2010-05-25 Bokslutskommuniké 2009
2010-03-16 Kvartalsrapport 2009-Q3
2009-12-08 Kvartalsrapport 2009-Q2
2009-09-14 Kvartalsrapport 2009-Q1
2009-06-29 Ordinarie utdelning SECT B 0.00 SEK
2009-06-26 Årsstämma 1
2008-06-26 Ordinarie utdelning SECT B 0.50 SEK
2007-06-29 Ordinarie utdelning SECT B 0.50 SEK
2006-06-29 Ordinarie utdelning SECT B 0.50 SEK
2000-08-11 Split SECT B 1:3

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Sectra är verksamt inom säkerhetslösningar. Störst affärsinriktning återfinns inom medicinteknik och cybersäkerhet. Bolaget utvecklar IT-lösningar som används bland sjukhus, institut och myndigheter på global nivå för hantering av kritisk infrastruktur samt känslig datainformation. Störst verksamhet återfinns inom den europeiska marknaden, där lösningarna säljs via flertalet dotterbolag. Sectra grundades 1978 och har sitt huvudkontor i Linköping.
2020-04-01 08:31:00

Linköping, Sweden and Shelton, CT - April 1, 2020 - International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) has received a 510(k) clearance by the US Food & Drug Administration (FDA). The clearance applies for Sectra Digital Pathology Module, the key component of Sectra's pathology solution, when used together with Leica Biosystems' scanner AT2 DX. This enables US healthcare providers to use Sectra's digital pathology solution for primary diagnostics. The solution makes it possible to move towards fully integrated diagnostics, which is especially important in complex cancer cases.

"I'm excited that with the FDA approval, we are now able to offer US healthcare providers a digital pathology offering with a proven track-record of use for full-scale primary diagnostics and large volumes," says Mikael Anden, President, Sectra Inc. "Our solution makes it possible for pathologists across the country to continue their important work from home without the need for a microscope. We look forward to providing uninterrupted pathology reading in these challenging times. This approval is an exciting and important step forward for pathology and cancer care in the US." 

Sectra's digital pathology solution is already used in the US for research and tumor boards and can now also be used in primary diagnostics. With digital images of tissue samples instead of physical glass slides, pathologists gain instant access to current and historical images and related data as well as to digital tools for reviewing the images. Digital access also facilitates efficient second opinions, remote reading, specialist consultations and makes integrated diagnostics possible.

The digital pathology solution is a component of Sectra's enterprise imaging offering, of which all components are built on the same technical platform. This allows healthcare providers to use a single solution for their medical imaging needs across all specialties, enabling integrated diagnostics. A deeper cooperation and ability to access other departmental images and information contributes to improved efficiency and patient care. This is especially important for complex cases where both radiology and pathology play key roles. Instant access to digital pathology images, side by side with radiology or other images, enables more efficient discussions and the ability to give detailed descriptions of findings.

"Pathology is the next huge digitization of healthcare. The use of glass slides limits growth in today's increasingly digital environment, especially in consolidated health care systems where potential synergies cannot be reached unless pathology is digitized. Our solution opens up new opportunities in the US where we can point to our successes in Europe in large production centers," says Dr. Torbjörn Kronander, President and CEO of Sectra.

Watch this video (https://youtu.be/g_oXh4kp770) to learn more about how digital pathology can enable increased efficiency and higher precision for the pathologists. 

About Sectra Imaging IT Solutions
With more than 30 years of innovation and 2,000 installations worldwide, Sectra is a leading global provider of imaging IT solutions that support healthcare in achieving patient-centric care. Sectra offers an enterprise imaging solution comprising PACS for imaging-intense departments (radiology, pathology, cardiology, orthopedics), VNA, and share and collaborate solutions. Read more about Sectra and why Sectra PACS is "Best in KLAS" for a seventh consecutive year at https://medical.sectra.com/.